These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18033317)

  • 1. Use of pegylated recombinant filgrastim (Pegfilgrastim) in patients with acute myeloid leukemia: pharmacokinetics and impact on leukocyte recovery.
    Fiegl M; Hiddemann W; Braess J
    Leukemia; 2008 Jun; 22(6):1284-5. PubMed ID: 18033317
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal stimulation of acute myeloid leukemia blasts by pegfilgrastim.
    Duval C; Boucher S; Moulin JC; Gourieux B; Mauvieux L; Leveque D; Herbrecht R
    Anticancer Res; 2014 Nov; 34(11):6747-8. PubMed ID: 25368285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy.
    Weycker D; Malin J; Barron R; Edelsberg J; Kartashov A; Oster G
    Am J Clin Oncol; 2012 Jun; 35(3):267-74. PubMed ID: 21378538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma.
    Fenk R; Hieronimus N; Steidl U; Bruns I; Graef T; Zohren F; Ruf L; Haas R; Kobbe G
    Exp Hematol; 2006 Oct; 34(10):1296-302. PubMed ID: 16982322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia.
    Heaney ML; Toy EL; Vekeman F; Laliberté F; Dority BL; Perlman D; Barghout V; Duh MS
    Cancer; 2009 Oct; 115(20):4839-48. PubMed ID: 19637341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.
    Frank T; Klinker F; Falkenburger BH; Laage R; Lühder F; Göricke B; Schneider A; Neurath H; Desel H; Liebetanz D; Bähr M; Weishaupt JH
    Brain; 2012 Jun; 135(Pt 6):1914-25. PubMed ID: 22427327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
    Cucuianu A; Petrov L; Ghiurt A; Vasilache A
    Rom J Intern Med; 1996; 34(1-2):97-103. PubMed ID: 8908636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim.
    Draper BK; Robbins JB; Stricklin GP
    J Am Acad Dermatol; 2005 May; 52(5):901-5. PubMed ID: 15858487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony stimulating factor.
    Nguyen YK
    J Fla Med Assoc; 1994 Jul; 81(7):467-9. PubMed ID: 7525857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the biologic and therapeutic effects of granulocyte colony-stimulating factor (filgrastim) in patients with acute myelogenous leukemia.
    Jakubowski A; Gordon M; Tafuri A; Schuster S; Andreeff M; Shieh JH; Vincent M; Gabrilove J
    Leukemia; 1995 Nov; 9(11):1799-804. PubMed ID: 7475265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
    Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y
    Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model.
    Kotto-Kome AC; Fox SE; Lu W; Yang BB; Christensen RD; Calhoun DA
    Pharmacol Res; 2004 Jul; 50(1):55-8. PubMed ID: 15082029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.
    Milano-Bausset E; Gaudart J; Rome A; Coze C; Gentet JC; Padovani L; Lacarelle B; André N
    Clin Ther; 2009; 31 Pt 2():2388-95. PubMed ID: 20110048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
    Rifkin R; Spitzer G; Orloff G; Mandanas R; McGaughey D; Zhan F; Boehm KA; Asmar L; Beveridge R
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):186-91. PubMed ID: 20511163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of recombinant human granulocyte colony-stimulating factor on protracted neutropenia in patients with acute myelogenous leukemia. (rG.CSF Clinical Study Group)].
    Kimura Y; Toyama K; Hirashima K; Okuma M; Saito H; Ohno R; Ikeda Y; Tomonaga M; Asano S
    Rinsho Ketsueki; 1995 Jun; 36(6):589-96. PubMed ID: 7543954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].
    Takeshita A; Ohno R; Hirashima K; Toyama K; Okuma M; Saito H; Ikeda Y; Tomonaga M; Asano S
    Rinsho Ketsueki; 1995 Jun; 36(6):606-14. PubMed ID: 7543956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.